版本:
中国

BRIEF-Akebia announces publication of phase 2A results for Vadadustat in patients with anemia related to chronic kidney disease

March 28 Akebia Therapeutics Inc

* Akebia Therapeutics Inc - Akebia announces publication of phase 2A results for Vadadustat in patients with anemia related to chronic kidney disease

* Akebia Therapeutics Inc - data showed Vadadustat increased hemoglobin levels and improved iron mobilization when compared to placebo Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐